Invention Grant
![N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamides](/docs/US/2018-02-06/US09884854B2/abs.jpg.600x600.jpg)
- Patent Title: N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamides
-
Application No.: US15485262Application Date: 2017-04-12
-
Publication No.: US09884854B2Publication Date: 2018-02-06
- Inventor: Doris Riether , Marco Ferrara , Niklas Heine , Uta Friederike Lessel , Janet Rachel Nicholson , Anton Pekcec , Stefan Scheuerer
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Marc Began; Usha R. Patel
- Priority: EP16165538 20160415
- Main IPC: C07D413/12
- IPC: C07D413/12 ; C07D403/04 ; C07D401/14 ; C07D401/12
![N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamides](/abs-image/US/2018/02/06/US09884854B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel N-[(Pyrimidinylamino)propanyl]- and N-[(Pyrazinylamino)-propanyl]arylcarboxamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with the orexin sub-type 1 receptor.
Public/Granted literature
- US20170298053A1 NOVEL N-[(PYRIMIDINYLAMINO)PROPANYL]-AND N [(PYRAZINYLAMINO)PROPANYL]ARYLCARBOXAMIDES Public/Granted day:2017-10-19
Information query
